NeoGenomics specializes in cancer genetics testing and information services. We provide one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer with >600 tests available in-house including extensive molecular profiling in myeloid disorders and leukemias, cfDNA/RNA assays for biopsy-free evaluation of hematologic cancers, and >20 HemeFISH™ panels. Our Pharma Services Division serves pharmaceutical clients in clinical trials and drug development to meet program objectives and delivery from biomarker discovery through CDx validation and commercialization. Collaborations are welcome. For resources specific to ASCO2020, visit https://neogenomics.com/asco2020.